Report: Eli Lilly Faces $4 Billion More To Settle Zyprexa Cases

Lilly faces at least $4 billion more in settlement monies to shut down the remaining lawsuits brought against the company over its handling of Zyprexa, its $4 billion-plus selling antipsychotic. The remaining cases involve unions, insurance companies and pension funds who've sued the company in federal court in New York State plus remaining lawsuits by 12 states who were not part of last week's $1.42 billion settlement between Lilly and the feds plus about 30 other states.